Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.9508
-0.0426 (-4.29%)
May 8, 2025, 11:52 AM - Market open
Sutro Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 190.3 | 69.27 | 47.25 | 30.41 | 206.15 | Upgrade
|
Short-Term Investments | 126.59 | 306.35 | 287.11 | 167.52 | 161.99 | Upgrade
|
Cash & Short-Term Investments | 316.9 | 375.62 | 334.36 | 197.94 | 368.14 | Upgrade
|
Cash Growth | -15.63% | 12.34% | 68.92% | -46.23% | 212.34% | Upgrade
|
Receivables | 8.62 | 36.08 | 7.12 | 12.45 | 5.56 | Upgrade
|
Prepaid Expenses | 17.8 | 9.85 | 11.67 | 8.12 | 4.49 | Upgrade
|
Total Current Assets | 343.31 | 421.54 | 353.15 | 218.52 | 378.18 | Upgrade
|
Property, Plant & Equipment | 35.87 | 44.76 | 51.06 | 51.59 | 12.94 | Upgrade
|
Long-Term Investments | - | - | - | 68.78 | - | Upgrade
|
Other Long-Term Assets | 8.03 | 4.44 | 2.73 | 2.53 | 2.99 | Upgrade
|
Total Assets | 387.21 | 470.74 | 406.94 | 341.41 | 394.11 | Upgrade
|
Accounts Payable | 10.48 | 9.44 | 4.8 | 6.01 | 5.54 | Upgrade
|
Accrued Expenses | 40.13 | 34.1 | 24.83 | 17.07 | 8.82 | Upgrade
|
Current Portion of Long-Term Debt | - | 4.06 | 12.5 | 9.38 | - | Upgrade
|
Current Portion of Leases | 7.48 | 6.42 | 4.59 | 1.04 | - | Upgrade
|
Current Income Taxes Payable | 0.02 | 15.17 | - | - | - | Upgrade
|
Current Unearned Revenue | 69.78 | 20.67 | 16.76 | 5.5 | 14.6 | Upgrade
|
Other Current Liabilities | 4.01 | 3.9 | 3.08 | 2.75 | 0.63 | Upgrade
|
Total Current Liabilities | 131.89 | 93.75 | 66.55 | 41.74 | 29.6 | Upgrade
|
Long-Term Debt | - | - | 3.77 | 15.74 | 24.55 | Upgrade
|
Long-Term Leases | 15.67 | 23.15 | 29.57 | 31.22 | - | Upgrade
|
Long-Term Unearned Revenue | 193.35 | 202.49 | 89.89 | - | 6.1 | Upgrade
|
Other Long-Term Liabilities | 1.69 | 1.69 | 0.12 | 0.15 | 1.82 | Upgrade
|
Total Liabilities | 342.61 | 321.09 | 189.9 | 88.84 | 62.06 | Upgrade
|
Common Stock | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 | Upgrade
|
Additional Paid-In Capital | 831.35 | 708.98 | 670.22 | 586.24 | 559.75 | Upgrade
|
Retained Earnings | -786.87 | -559.41 | -452.62 | -333.41 | -227.87 | Upgrade
|
Comprehensive Income & Other | 0.04 | 0.02 | -0.62 | -0.31 | 0.13 | Upgrade
|
Total Common Equity | 44.6 | 149.65 | 217.05 | 252.56 | 332.05 | Upgrade
|
Shareholders' Equity | 44.6 | 149.65 | 217.05 | 252.56 | 332.05 | Upgrade
|
Total Liabilities & Equity | 387.21 | 470.74 | 406.94 | 341.41 | 394.11 | Upgrade
|
Total Debt | 23.15 | 33.64 | 50.43 | 57.37 | 24.55 | Upgrade
|
Net Cash (Debt) | 293.74 | 341.98 | 283.93 | 209.34 | 343.59 | Upgrade
|
Net Cash Growth | -14.11% | 20.45% | 35.63% | -39.07% | 177.99% | Upgrade
|
Net Cash Per Share | 3.82 | 5.68 | 5.60 | 4.54 | 10.55 | Upgrade
|
Filing Date Shares Outstanding | 83.78 | 62.44 | 60.16 | 46.38 | 45.89 | Upgrade
|
Total Common Shares Outstanding | 82.53 | 61.01 | 57.5 | 46.33 | 45.75 | Upgrade
|
Working Capital | 211.42 | 327.8 | 286.61 | 176.78 | 348.59 | Upgrade
|
Book Value Per Share | 0.54 | 2.45 | 3.77 | 5.45 | 7.26 | Upgrade
|
Tangible Book Value | 44.6 | 149.65 | 217.05 | 252.56 | 332.05 | Upgrade
|
Tangible Book Value Per Share | 0.54 | 2.45 | 3.77 | 5.45 | 7.26 | Upgrade
|
Machinery | 42.12 | 40 | 37.63 | 31.82 | 32.79 | Upgrade
|
Construction In Progress | 0.5 | 0.5 | 1.69 | 0.51 | 1.08 | Upgrade
|
Leasehold Improvements | 24.21 | 23.61 | 23.22 | 23.65 | 15.9 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.